Experience

Marc Recht

    • Prevail Therapeutics Closes $50 Million Series B 


    • Morphic Therapeutics - $104 Million IPO 


    • Prevail Therapeutics $125 Million IPO 


    • Milestone Pharmaceuticals – $95 Million IPO 


    • Genfit - $155 Million IPO 


    • Avedro – $70 Million IPO 


    • ERYTECH – $144 Million IPO 


    • Cooley Advises on Nightstar + NuCana IPOs 


    • Tarveda Raises $30 Million Series D Financing 


    • ERYTECH Closes €70.5 Million Private Placement to US + European Investors 


    • Selecta Biosciences – $74 Million IPO 


    • Cooley Advises ERYTECH on €25.4 Million Private Placement 


    • ERYTECH Private Placement 


    • Voyager Therapeutics - $80.5 Million IPO 


    • Celyad Completes IPO 


    • Cooley Advises Immunocore on Largest European Private Life Sciences Financing on Record 


    • Immunocore Limited Series A $320 Million Financing 


    • DBV Technologies – $281.5 Million Follow-On Offering  


    • DBV Technologies Completes Concurrent Public Offerings 


    • FORMA $600 Million Collaboration with Celgene 


    • Eagle $50 Million Initial Public Offering 


    • Flexion $74 Million Initial Public Offering 


    • Genocea Biosciences IPO 


    • Cooley Advised Flexion on Initial Public Offering 


    • FORMA Therapeutics $200M Strategic Collaboration Deal with Celgene 


    • Minerva – $58 Million Follow-On Offering 


    • Merus IPO – $61 Million